A showcase of chemistry-led innovation for the investment community 10 June 2024 | London, UK THE INVESTMENT CATALYST
We are an international organisation connecting chemical scientists with each other, with other scientists, and with society as a whole. Founded in 1841 and based in London, UK, we have an international membership of over 60,000. We use the surplus from our global publishing and knowledge business to give thousands of chemical scientists the support and resources required to make vital advances in chemical knowledge. We develop, recognise and celebrate professional capabilities, and we bring people together to spark new ideas and new partnerships. We support teachers to inspire future generations of scientists, and we speak up to influence the people making decisions that affect us all. We are a catalyst for the chemistry that enriches our world.
ANDREW WATERWORTH Enterprise Impact Programmes Manager responsible for Investment and Growing Enterprises Royal Society of Chemistry waterwortha@rsc.org
CONTACT INFORMATION Contact Name: Victoria Garcia E-mail: victoria@bindethics.com Website: www.bindethics.com Funding required: £600,000 Already raised: £350,000
THE SOLUTION BindEthics offers a transformative solution with Ecohesive™, our food waste-derived bio-adhesive. This sustainable alternative is non-toxic and fossil fuel-free, boasting an 80% reduction in CO2 emissions compared to conventional adhesives. By replacing formaldehyde-based glues, we enable the production of fully recyclable and biodegradable engineered wood products, integrating seamlessly into the circular economy. Our unique formulation is designed for direct market integration at a cost competitive with traditional petrochemical-based adhesives. Proven through rigorous lab-scale trials, Ecohesive™ ensures both environmental and economic benefits.
Sustainable binder for engineered-wood boards derived from food waste. BindEthics has developed innovative food waste-derived bio adhesives to replace formaldehyde-based glues used to make engineered wood products such as furniture. Formaldehyde-based adhesives, the industry standard in a growing market that accounts for £16 Billion a year, are toxic, carcinogenic, and the reason why wood panels are non-recyclable. Ecohesive™ is our sustainable solution. It reduces the CO 2 footprint by 80 % and allows the final piece of furniture to fall within the circular economy cycle. Our collaborative approach and proven technology, positions us as the ideal partner for manufacturers seeking to meet new regulatory requirements and the demands of environmentally conscious consumers. THE PROBLEM Engineered wood panels, including popular furniture items like IKEA boards, are bound together using formaldehyde-based adhesives, making them non-recyclable and environmentally hazardous. These toxic binders contribute to landfills, releasing harmful emissions and precluding energy recovery through incineration. As global environmental regulations tighten, mandating lower emissions and greater sustainability, the industry faces urgent pressure to adopt safer, greener alternatives.
CONTACT INFORMATION Contact Name: Christopher Hunter E-mail: Chris.hunter@colorifix.com Website: www.colorifix.com Funding required: £20m Already raised: Term sheet discussions commencing for current round. £27m raised in aggregate over previous rounds of capital raising, plus £7m in grant funding. ELEVATOR PITCH Colorifix is a UK-based biotech that has developed an entirely biological process to produce, deposit and fix pigments onto textiles. THE PROBLEM Industrial textile dyeing consumes massive amounts of water and energy and has an enormous carbon footprint. Additionally, it is one of the most chemically intensive industries on earth and one of the largest polluters of increasingly scarce freshwater. Though an exact figure is difficult to determine, it is estimated that 20% of industrial water pollution comes from textile dyeing and treatment. The majority of the textile industry worldwide uses azo dyes that are derived from petrochemicals. Many of these synthetic dyes are highly toxic and around 200,000 tons are lost annually to wastewater, flowing into rivers and streams, and causing devastating effects to the natural environment and human health.
THE SOLUTION Colorifix has developed an entirely biological process to produce, deposit and fix pigments onto textiles. Fusing advanced technology and age-old processes from nature it offers the most scalable, environmentally friendly, alternative to traditional dyeing technologies. The Colorifix solution cuts out all harmful chemicals and significantly reduces consumption of water and energy, whilst still meeting key industry standards on quality. The first step in the Colorifix process is to identify a pigment produced by a plant, animal, insect, or microbe. Via DNA sequencing, we pinpoint the genetic information that codes for the production of our chosen colour. We then translate that message into our engineered microorganism, which we use to grow, transfer, and fix colour onto textiles. Fashion brands such as H&M, Pangaia and Vollebak have launched garments dyed with the Colorifix technology.
CONTACT INFORMATION Contact Name: Rob Harris E-mail: Rob.Harris@descycle.com Website: www.descycle.com Funding required: £8-12 million
This integration with existing recyclers is key to disruption. We offer them a sustainable solution to recycle metals on-site, rather than be forced to sell their recycling outputs (PCBs) at low values. This will enable circular economies to be created at scale locally and stop the export and transport of a hazardous waste recycling market. THE SOLUTION E-waste recycling, the world’s fastest growing waste stream, growing from an annual total of US$91bn in 2022 to $120bn by 2030. DEScycle aims to recycle the precious and critical metals in E-waste, of which printed circuit boards are the primary feedstock. The UK is the world’s second highest generator of E-waste per capita, producing 23.9kg/person/year, and currently has no capacity to fully recycle metals from E-waste. Currently, E-waste is only recycled by sending to highly pollutive and energy intensive smelters outside the UK, where the metals are now lost from the UK’s circular economy. DEScycle’s technology solution is a low energy, non-toxic and low CO 2 footprint and can recover greater than 99% of metals contained in the E-waste. These metals once processed by DEScycle’s technology, will then be sold back to industries who will reform these materials into new products. The plastics are not damaged during the leaching process using DES and can be resold or reprocessed by plastics recyclers. Our technology reduces the need for smelting, benefiting the environment and encourages existing waste collectors and recyclers to increase collection rates which will greatly support the circular economy and reduce waste to close to zero.
Already raised: £5 million (verbal commitment only)
ELEVATOR PITCH Sustainable E-waste recycling using Deep Eutectic Solvents. DEScycle have developed a chemistry- based solution to recycle the world’s largest growing waste stream, E-waste, using Deep Eutectic Solvents (DES). DES are non-toxic, biodegradable, and recyclable solvents that replace the need for toxic and pollutive smelters or the need for the use of dangerous chemicals. THE PROBLEM DEScycle aims to recycle the precious and critical metals in E-waste, of which printed circuit boards are the primary feedstock using novel, environmentally sustainable chemistries known as Deep Eutectic Solvents (DES). Once captured and recovered by the DES, these metals will then be sold back to industries who will reform these materials into new products. We are addressing this by developing a zero carbon, zero particulate emission recycling process to replace the environmentally damaging process of smelting (the current method of metals recycling from E-waste). Our process is also remarkably capital light, allowing for the first time, sophisticated metals recycling to take place on a local scale rather than using billion dollar smelting operations.
CONTACT INFORMATION Contact Name: Dr Asel Sartbaeva E-mail: asel@ensilitech.com Website: www.ensilitech.com Funding required: £4.5M Already secured: £750,000
refrigeration equipment producing 6x the NOx and 29x the particulate pollution of the engine providing traction. This produces a significant amount pollution that is extremely harmful to the populations around these transportation routes, with numerous studies citing the adverse effects. THE SOLUTION EnsiliTech have developed a novel chemical method to improve the thermal stability and extend the shelf-life of life-saving vaccines and other biopharmaceuticals. Our ensilication method can be easily incorporated into existing manufacturing processes to encase vaccine components in a protective silica nano-layers, meaning they can be stored and transported at elevated temperatures. Our universal solution enables significant cost savings and environmental benefits for the biopharmaceutical supply chain, as well as reducing vaccine wastage and contributing to vaccine equity by greatly improving access to life-saving medicines globally. ECONOMIC IMPACT The direct and indirect costs associated with cold chain vaccination programs account for up to 80% of the vaccination costs. The World Health Organisation (WHO) estimates up to 10-25% of vaccines are wasted globally every year, largely due to cold-chain failures. Pharmaceutical manufacturers, NGOs, Governments, and aid-charities will benefit from significantly improved investment efficiency in deploying vaccine programs. SOCIAL IMPACT A temperature-stable vaccine will improve democratised vaccine access to low/middle income countries that suffer from high temperate climates. Ensilication will improve access to life-saving treatments, and improve vaccination rates. This will directly reduce hospitalisation rates and will alleviate healthcare burden. Vaccination directly helps the survivability of children less than five years old, a direct correlation between infant mortality and birth rates has been proven. ENVIRONMENTAL The use of ensilication could reduce the vaccine supply CO 2 output by up to 90%, saving more than 1.5 billion tones of CO 2 every year. By removing vaccine wastage, we can significantly reduce the amount of medicine and packaging wastage, resulting from vaccination programs. Vaccines help reduce antibiotic use, preventing and controlling infectious diseases both in humans and in animal populations, helping to fight against the growth of antimicrobial resistance.
ELEVATOR PITCH Ensilitech have developed a method that can free vaccines and other biopharmaceuticals from cold chain dependence. This will significantly reduce vaccine wastages, energy needed for fridges and freezers, and potentially can save millions of lives worldwide by increasing vaccine availability. THE PROBLEM Many vaccines degrade at room temperature, and so are currently stored and transported at 2-8°C, relying on a global network of fridges known as the cold supply chain. It is extremely expensive, and prone to regular failure, meaning many low- and middle-income countries have poor access to these life-saving products. This is a contributing factor of 10-25% of vaccine being wasted (up to 50% in some countries), and 1.5 million infants still dying from vaccine- preventable diseases every year, globally. The wastages are even higher for mRNA vaccines, which require ultra cold-chain transport and storage of up to -20C or -80C. Developments in mRNA vaccine technologies have sped up since covid-19 pandemic as two covid-19 vaccines, based on mRNA technologies have gained emergency approvals (Pfizer-BioNTec and Moderna covid-19 vaccines). A recent study on CO 2 outputs of mRNA vaccines in Germany has identified that 99% of the CO2 outputs were due to transport and storage, mainly coming from cold-chain maintenance. In 2021 alone it was estimated that 1.53 billion tonnes of CO2 were produced in the transportation and storage of vaccines administered globally. Even focusing on a more local perspective, refrigerated trucks and trailers used to transport cold chain biopharmaceuticals are not beholden to the emissions regulations of regular vehicles, with the motors running the
CONTACT INFORMATION Contact Name: Nick Whitehurst E-mail: nick@figura-analytics.co.uk Website: www.figura-analytics.co.uk Funding required: £2,000,000
THE SOLUTION Using our patented nanopore technology platform we can count the size and shape of all particles in a liquid sample, that pass through our microfluidic electrochemical flowcells. Our vision is that we will replace the microscope, plating and waiting, as the primary means of spotting a contaminant in liquid. Since 1676 the microscope has been at the forefront of identifying contaminants in liquid and we think it’s time for a change!
ELEVATOR PITCH Revolutionising liquid analysis via our nanopore technology platform. We count particles, of all shapes and sizes, to give you a ‘fingerprint’ of what your sample should look like. Seeing and understanding this, and rapidly identifying potential contaminants, will help you solve problems fast and get back to what you do best. THE PROBLEM Analysing liquids for quality control and contaminants is a multi £BN market, spanning life sciences, food, and drink and through to semi-conductor manufacturing. In many industry sectors current methods are time consuming or inadequate, leading to delays in supply chains and effective decision making. The ability to speed up analysis is fully verified and there is demand for new solutions to tackle this problem. Our technology provides faster and smarter information to industrial operators and clinicians helping them to make better decisions, keeping people and products safe. Figura Analytics provides analytical information not available at scale before, in real time, enabling industries to drive efficiencies, to ensure great processes are maintained and to spot contaminants where they occur, faster than ever before.
CONTACT INFORMATION Contact Name: Dr Monica Saavedra E-mail: Monica@lambda.energy Website: https://www.lambda.energy Funding required: £550,000 Already raised: £190,000
greenhouse materials, or by applying them in a paint-based spray-on coating. Our first field tests at Cranfield University yielded a 9.3% increase in the yield (dry mass) of Basil. THE SOLUTION The novel technology: 1) reduces greenhouse reliance on artificial lighting, leading to 25% lower energy consumption and consequently an annual reduction of CO2 emissions by 20,000 tons. This reduces OPEX for growers and in turn reduces the cost of fruits and vegetables, enabling healthier diets. 2) increases crop yields by circa 20%, decreasing food costs, increasing food- security and profitability for growers. Increase in food production enables decreased land use, limiting deforestation, underground waterways depletion etc. Increased crop yields will lead to a reduction in the amount of plastic and glass required and the emissions associated with plastic and glass siding production. 3) decreases greenhouse temperatures making the produce more resilient to global-warming and hot countries, thereby increasing food- security. Heat reduction also reduces the amount of CO 2 pumped into a greenhouse (and therefore the associated electricity and carbon footprint) due to a decreased reliance on greenhouse venting. 4) increases the wettability of the greenhouse sidings, enabling self-cleaning of the surfaces by guiding dirt to the edges, reducing the frequency of greenhouse cleaning. 5) increases the adaptability of the plants to their environment, enabling local food production, reducing the reliance on imported food and cutting emissions associated with international transportation.
ELEVATOR PITCH Light Management - better light for plants and other applications. Our materials absorb short-wavelength light and re-emit at longer wavelengths. The first, and most prominent, application is in protected agriculture (greenhouses, polytunnels), where the increase in red light leads to a significant increase in crop yield, without the need for electricity. THE PROBLEM Food shortages are, unfortunately, becoming a problem even in industrialised nations, such as the UK. Part of the problem is our dependence on food imports, made necessary by our inability to grow enough food crops domestically in an economically viable fashion. Protected growing environments (greenhouses and polytunnels) require, aside from high CAPEX, high OPEX. The biggest factor in the latter is the cost of electricity for the LED lighting that provides enough red light for optimal crop yields. Lambda’s technology converts incoming sunlight to have a higher proportion of red light, making it a cost-saving alternative / supplement to LED lighting. Aside from the wavelength change, our materials also help scatter the incoming light, which is another proven way of increasing crop yields. We can employ our materials in or on all commonly used greenhouse panelling materials, including glass, polycarbonate, and PMMA, either by direct incorporation into the top layers of the
CONTACT INFORMATION Contact Name: Dr George Frodsham E-mail: george@medisieve.co.uk Website: www.medisieve.com Funding required: £4,000,000
THE SOLUTION MediSieve’s Magnetic Blood Filtration (MBF) is a groundbreaking innovation, offering precision in disease management and therapy enhancement. This technology selectively removes or isolates specific substances from the bloodstream, like pathogens, antibodies, and cells. Effective in a wide range of conditions, including inflammation, oncology, and autoimmune disorders, it allows targeted treatment, significantly outperforming broad- spectrum methods. The platform consists of the Capture System (Filter and Magnet) and Magnetic Beads. The Beads, magnetic particles engineered to bind specific clinical targets, are introduced into circulating blood via an extracorporeal circuit. This blood then passes through the MediSieve Filter, housed within the Magnet, capturing the Beads and their bound targets, preventing their re-entry into the patient. The use of beads and their capability to target virtually any substance depending on the surface ligand enables the technology’s application across a wide range of clinical scenarios. The impact of MBF technology is particularly significant in the field of AAV gene therapies. By extracting neutralising antibodies, MediSieve’s technology addresses pre-existing immunity, doubling the pool of eligible patients and enabling redosing for long-term treatment success. Furthermore, MBF holds the potential to revolutionise medical research and therapeutic practices by providing a means to efficiently isolate valuable substances from the blood for diagnostic and research purposes. By selectively removing and isolating substances from the blood, MediSieve’s technology fills a critical gap in medical treatment, aiming to enhance quality of life worldwide and advancing the precision and efficacy of clinical interventions and disease understanding.
ELEVATOR PITCH MediSieve uses advanced magnetic filtration to selectively remove or isolate blood substances, driving a paradigm shift in global healthcare. THE PROBLEM MediSieve is addressing the critical medical issues caused by the circulation of specific components in blood and the inability of current technologies to selectively target them. The bloodstream carries a variety of substances, including pathogens, cells, and antibodies, which can either cause diseases, hinder therapeutic treatments, or hold valuable information. This issue is particularly pronounced in Adeno- Associated Virus (AAV) Gene Therapies, MediSieve’s first use case. Neutralising antibodies (nAbs) in a patient’s bloodstream can block AAV capsids from reaching their intended targets, therefore compromising the effectiveness of the treatment. This makes approximately 880,000 people, or up to 60% of potential patients, ineligible for a therapy that often stands as the only treatment option for various rare diseases. The core challenge lies in the effective removal or isolation of these substances from blood. Traditional broad-spectrum methods are slow and non-specific, making them ineffective at achieving the necessary capture rates required to mitigate the issues these components pose. This highlights a significant gap in current medical practices, underscoring the pressing need for a targeted approach that MediSieve’s technology aims to fulfil.
CONTACT INFORMATION Contact Name: Yubiao Niu E-mail: yubiao@wearenium.com Website: www.wearenium.com Funding required: £10-20M Already raised: £3.2M
chain resilience and demonstrating world- class production through developing a low- temperature, low- pressure ammonia synthesis process.
THE SOLUTION Economic Impact: Short-term, decentralised chemical energy storage solution will enable scaling of renewable energy storage sites, securing competitive advantage in emerging hydrogen economy. At larger sites, CAPEX/ OPEX reduced by 98.5% compared to Haber- Bosch process. Global/Supply chain: Ammonia can unlock hydrogen economy by delivering zero-carbon energy vector. UK economy: Project commercialised from UK; ˃85% of project revenues (£21.6m/year, FYE2030) will be exports. Environmental Impact: Enabling small-scale, short-term renewable energy storage, ultimately reducing reliance on domestic and imported fossil fuels, and reducing CO2 emissions compared to deploying natural gas peaking plants for short-term energy storage. Globally, ammonia produced via Haber-Bosch already contributes around 1.8% of global carbon dioxide emissions. Compared to Haber-Bosch, initial modelling indicates green ammonia production process developed in this project could reduce Scope 1&2 CO2e emissions by 97% (from 2.84 to 0.082 tonnes CO 2 e/tonne ammonia), creating significant potential for reduction in CO 2 e emissions as we scale technology across ammonia applications (e.g., transport, agriculture). Societal Impact: Aligned with net zero, renewable energy, hydrogen, biotechnology, catalysis, innovation strategies. Increasing national self-sufficiency. Developing skills and capacity (catalysis science).
ELEVATOR PITCH Green ammonia on demand. Nium is a pioneering climate company
committed to eliminating emissions at scale through innovative nanotechnology solutions and pushing the boundaries of science for a better tomorrow. Nium currently applies nanotechnology and engineering to produce green ammonia on demand with zero direct emissions for a cleaner future of food and fuel. THE PROBLEM Ammonia is increasingly recognised as a highly promising solution for long-term, large-scale, low-carbon energy storage and is expected to play a key role in meeting national and international net-zero emissions targets. However, today most ammonia is produced by the high-temperature, high- pressure Haber- Bosch process. This process consumes 1-2% of the global energy budget, contributes around 1.8% of global carbon dioxide emissions, and requires large-scale, capital-intensive equipment. Nium is a start-up formed in 2022 on Carbon 13, the venture builder for the climate emergency. Our goal is to remove 10 million tonnes/year of CO 2 equivalent emissions by 2030. We are developing patent-pending nanotechnology that enables low-temperature, low-pressure production of ammonia on demand, unlocking the use of ammonia in short-term, decentralised energy storage applications. Nium’s technology will reduce carbon emissions, energy consumption, and costs, while increasing supply
CONTACT INFORMATION Contact Name: Adrian Black E-mail: adrian@sonichem.com Website: www.sonichem.com Funding required: £2,500,000 Already raised: £1,200,000
Such a shift could revolutionise the chemical industry by meeting the growing demand for green chemicals and help to foster a sustainable, circular economy. THE SOLUTION Sonichem offers a unique solution to the quest for sustainable chemicals. Central to our innovation is an ultrasonic biorefinery process that transforms forestry by-product; sawdust into valuable bio-based chemicals, including lignin, cellulose, and hemicellulose sugars. Our process’s innovative application of ultrasonics allows us to break down woody biomass efficiently, without resorting to high temperatures, pressures, or corrosive chemicals. Further distinguishing Sonichem’s innovative approach is the production of high-quality, pure, low molecular weight lignin, an aromatic chemical that is the only viable bio-based alternative to petrochemicals including phenol, which are extensively utilised in resins and coatings for materials manufacturing. Unlike traditionally extracted lignin that often carries sulphur contamination and exhibits high molecular weight, making it less suitable for industrial use, Sonichem’s lignin is versatile and adaptable for a myriad of applications. By offering a scalable, environmentally friendly solution, Sonichem not only presents an urgent answer to the demand for sustainable petrochemical substitutes but also amplifies the economic value of biomass waste. For every £1 of sawdust processed, Sonichem’s technology can generate £8 worth of bio-based chemicals, multiplying economic returns for foresters and farmers by eight. This process not only promotes sustainable biomass management but also positions Sonichem as a pioneer in the green chemistry movement. This method is perfectly aligned with the industry’s shift towards sustainability, providing an option that greatly reduces reliance on fossil fuels, minimises CO² and particulate emissions, and could shift the industry closer to a green circular economy.
ELEVATOR PITCH Sonichem transforms low-value woody biomass into high-value bio-based chemicals with its proprietary ultrasonic biorefinery process. This pioneering technology positions Sonichem at the forefront of sustainable chemistry, offering an energy-efficient, clean alternative to traditional biorefinery processes. By producing eco- friendly, bio-based chemicals for a wide array of applications, Sonichem taps into the rapidly growing market for sustainable chemicals. With a focus on innovation and meeting market demand, Sonichem is poised to capitalise on the significant commercial opportunity presented by bio-based products, propelling the chemical industry towards a more sustainable future. THE PROBLEM The bio-based chemicals market, forecasted to continue to grow at an annual rate of 9%, reflects a pressing need for sustainable alternatives to petrochemicals, which are ubiquitous in modern life, from plastics to pharmaceuticals. However, the transition from fossil-based resources is hampered by substantial challenges. Most available bio-based solutions depend on food-grade crops, raising concerns over future global food security and sustainability. Meanwhile, woody biomass an underused but abundant resource, from forestry or agricultural by-products, is often underutilised or burnt contributing significantly to CO 2 emissions. In 2020 alone, 1.4 billion tonnes of forestry co- products were burned, highlighting a glaring inefficiency in renewable resource utilisation. Addressing this, there’s an urgent demand for innovative technologies that can convert tough low-value forestry and agricultural by-products into valuable bio-based chemicals.
CONTACT INFORMATION Contact Name: Daniel Stewart E-mail: dan@viridico2.co.uk Website: www.viridico2.co.uk Funding required: £5M Already raised: Follow on from Seed Investor (ca. £1-1.5M) ELEVATOR PITCH Catalysts to transform CO 2 into high-value chemicals. ViridiCO2 is a carbon dioxide (CO 2 ) solutions provider, enabling high CO 2 emitting manufacturers, such as chemical manufacturers and consumer product industries, to utilise CO 2 as a feedstock material in the synthesis of high- value chemical products. THE PROBLEM ViridiCO 2 enables manufacturers to directly replace petrochemical feedstocks (sourced from fossil fuels) with CO 2 . Our technology provides a solid-phase catalytic platform that requires far lower temperatures and pressures to utilise CO 2 than all other currently available technology. The platform can also be easily removed from synthesised products and re-used. Combined, these advantages provide a cheaper, faster, and more sustainable route for chemical production using carbon dioxide.
THE SOLUTION ViridiCO 2 technology has the potential to replace up to 50% of traditional petrochemical feedstocks with CO 2 , with further savings arising from the ability to utilise lower temperatures and pressures than traditional chemical synthesis.
NOTES
NOTES
HELP POWER POSITIVE CHANGE
THE CLIMATE CRISIS THE HEALTH CRISIS THE FOOD CRISIS…
We need solutions to the many challenges facing our world – and we know that deep tech chemistry has the power to change things for the better. Now, more than ever, we have a responsibility to support the chemists, the entrepreneurs and the ventures who have answers to the world’s problems, powering their technologies from idea to impact.
WHAT IS CHANGE MAKERS? We are Change Makers, a dynamic entrepreneurial ecosystem powered by the Royal Society of Chemistry and operating at the heart of deep tech chemistry. We focus on carefully selected ventures whose technology has the potential to make a positive impact on critical global issues, from advanced healthcare technologies to clean energy solutions. Our support aligns entrepreneurs, investors, Government and corporates as a whole, with the common goal of making a real difference. WE NEED YOUR EXPERTISE Our aim with Change Makers is to create a sustainable investment ecosystem, supporting ventures throughout their journey from spinout to scaleup. Deep tech chemistry ventures can disrupt global markets and shape future technologies, but to do this they require access to long-term intelligent finance: from early-stage angel investors to venture capitalist funds looking to support scaleup.
By becoming part of the Royal Society of Chemistry Change Makers investor community you’ll be doubly rewarded. You’ll gain access to ventures selected for their potential to deliver a return on investment. And you’ll actively contribute to the achievement of the UN’s Sustainable Development Goals by committing to ventures whose aligned technology is focused on issues such as climate change. Do you share our passion? If you’re interested in becoming a part of Change Makers please get in touch at changemakers@rsc.org. You should be prepared to invest in UK-based ventures operating in the deep tech chemistry space. THROUGH DEEP TECH CHEMISTRY, WE HAVE THE POWER TO CHANGE THINGS FOR THE BETTER. JOIN US. BE A CHANGE MAKER.
CHANGEMAKERS.RSC.ORG
Discover the venue for your next event
• Historic, award-winning venue • Central London location in Piccadilly • Impressive architecture • Delicious (and sustainable) catering • Audiovisual facilities, air con & free wifi • A bespoke, friendly service • 10% discount for RSC members
@RSCVenueHire
Take a look inside at rsc.li/venue-hire
RSC Venue Hire
Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16Made with FlippingBook Learn more on our blog